You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 9.0% | 7.1% |
| ROCE | 10.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | 44.8 | 59.6 |
| PEG | 0.4 | -2.4 |
| Price / Revenue | 4.5 | 4.2 |
| Price / Book value | 4.7 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 26.1% | -8.0% |
| PBT | 132.4% | n/a |
| EPS | 119.6% | -24.5% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | 3.27 | -2.87 | -8.70p | -2.9 | 0.0 | n/a | n/a | 0.0% |
| 2017-09-30 | 4.10 | -1.91 | -5.70p | -5.9 | 0.0 | n/a | n/a | 0.0% |
| 2018-09-30 | 5.39 | -0.79 | -2.00p | -13.5 | 0.0 | n/a | n/a | 0.0% |
| 2019-09-30 | 7.56 | 0.37 | 0.92p | 55.4 | 0.0 | n/a | n/a | 0.0% |
| 2020-09-30 | 9.53 | 0.86 | 2.02p | 48.0 | 0.4 | 120% | n/a | 0.0% |
| Ixico awarded £3.4m contract by existing client Sharecast News | 24 Dec |
|---|---|
| Ixico to provide neuroimaging solutions to unnamed global pharmaceutical group Sharecast News | 08 Dec |
| Ixico executes contract for Huntington's disease clinical trial Sharecast News | 27 Nov |
| IXICO selected by Cyclerion for a new AD study | 02-Mar-21 07:00 |
|---|---|
| Exercise of Options; PDMR Dealing | 01-Mar-21 17:25 |
| Conference attendance and presentations | 01-Mar-21 07:01 |
| PDMR Dealing | 29-Jan-21 10:20 |
| Result of AGM | 21-Jan-21 11:07 |